NSE filing, NSE: PROPSHOP. Summary written from the filing by ALFA Finder's alert engine.
Propshop Events and Exhibitions Ltd: key numbers
- Share price
- ₹66.00
- Market cap
- ₹96.56 Cr
- Revenue (annual)
- ₹70.29 Cr
- Net profit (annual)
- ₹8.02 Cr
- P/E (TTM)
- 12.1×Sector 36.4×
- Promoter holding
- 67.50%
- FII holding
- 1.53%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Propshop Events and Exhibitions Ltd
All →Propshop Events and Exhibitions Other Announcement
Propshop Events filed its quarterly Reg 32 statement confirming no IPO proceeds deviation. Of 2,304.6 lakh raised, 1,304.6 lakh is utilised and 1,000 lakh pending.
Propshop Events and Exhibitions H1 FY27 Results: Net Profit ₹4 Cr, Up 53.8% YoY
Propshop Events and Exhibitions Ltd reported revenue from operations of ₹34.5 Cr (+49.4% YoY) and net profit of ₹4 Cr (+53.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹4 Cr · +53.8% YoY
Propshop Events and Exhibitions Other Announcement
Propshop Events and Exhibitions Limited submitted a non-applicability certificate for Regulation 27(2)(a) of SEBI LODR Regulations regarding Corporate Governance for the quarter ended September 30, 2026.
Propshop Events and Exhibitions Annual General Meeting
Propshop Events and Exhibitions Limited held its 7th Annual General Meeting on September 30, 2026. The meeting transacted ordinary business, including adoption of financial statements.
Propshop Events and Exhibitions Annual General Meeting
Propshop Events and Exhibitions Limited has issued a notice for its 7th Annual General Meeting, scheduled to be held on September 30, 2026.
Propshop Events and Exhibitions H2 FY26 Results: Net Profit ₹5.4 Cr, Up 38.5% YoY
Propshop Events and Exhibitions Ltd reported revenue from operations of ₹47.2 Cr (+43.5% YoY) and net profit of ₹5.4 Cr (+38.5% YoY) for H2 FY26.
- Key figure
- Net profit ₹5.4 Cr · +38.5% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.